Navigation Links
Atlantica Group LLC to Support International "Soft-Landing" Efforts of Incubators and Accelerators
Date:3/26/2013

Portland, ME (PRWEB) March 26, 2013

Many communities have established business incubators and accelerators in an effort not only to support local entrepreneurs but to attract early-stage companies from around the world. The goal is to provide international start-ups with a "soft landing" to enable them first to establish themselves, and then to grow, prosper and add employees in the region.

The challenge faced by many incubators, however, is knowing where to find the right early-stage companies, how to qualify them, and then how to attract them. The competition is fierce, and it's easy to expend significant sums pursuing start-ups that may not have the best prospects for success, or may not be the best "fit" for the incubator or the region.

Atlantica Group LLC, an international business development firm based in Portland, Maine, understands these special challenges and has joined forces with an industry expert to support the efforts of incubators and economic development organizations in this challenging sector.

The firm announced today that Géraldine Quetin, one of Europe’s leading authorities on business incubation and early-stage company development, will join Atlantica Group as a Senior Adviser.

Quetin, who is based in Nice, France, has an extensive background in business incubation and early-stage company strategy. She launched one of the first technology incubators in the Paris region, managed a highly successful incubator in the south of France and led the French government’s Young Entrepreneur Initiative in the Boston area for two years. She holds a Master’s degree in Innovation and Technology Management, awarded jointly by the Université Paris-Dauphine, the École normal supérieur de Cachan, Mines ParisTech and the French Atomic Energy Commission.

“It’s well-known that early stage companies need a kind of ‘ecosystem’ of support, and business incubators provide many of the necessary resources comprising that ecosystem,” said Quetin. “But not all incubators are the same, and certainly not all companies are appropriate for every incubator. Well-managed incubators with a clearly-defined mission and strategy stand the best chance of attracting the early-stage technology companies that are the best “fit.”

Perry B. Newman, president and founder of Atlantica Group, agrees.
“Many incubators, communities and economic development organizations are seeking to attract early-stage companies on an international basis and to offer them a “soft landing” within an incubator. The challenge, of course, is to identify among the myriad promising early-stage firms which are the best, most appropriate candidates for a particular community and the soft-landing resources being offered,” said Newman.

“Géraldine Quetin has an exceptional background and we are delighted she’ll be working with us to help our clients focus their efforts and maximize international opportunities. With Géraldine’s input, we believe incubators, economic development organizations and early-stage companies can make the best use of their resources to achieve their international goals.”

Founded in 2000, Atlantica Group is an international business development firm based in Portland, Maine. Atlantica Group has worked with clients to develop international business development opportunities throughout North America, Europe, India and Israel.

[FRENCH LANGUAGE VERSION IS ATTACHED TO THIS RELEASE.]

Read the full story at http://www.prweb.com/releases/2013/3/prweb10568244.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Atlantica Group LLC to Support Global Business Incubation and "Soft Landing" Efforts
2. AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug
3. MiMedx Group, Inc. to Present at the 6th Annual Canaccord Genuity Cardiovascular, Aesthetics and Metabolic Disorders Conference
4. BioNeutral Group Receives $400,000 in Equity Financing
5. MiMedx Group Completes $5,000,000 Private Placement
6. Use Biomarkers in Alzheimers Disease Clinical Trials, Says Expert Group
7. MiMedx Group, Inc. Receives CE Certification for Its CollaFix™ Surgical Mesh CD
8. Lend Lease Announces the Appointment of Tom Chapman as Director Operations for the Life Sciences Group in the Atlantic Region
9. Statewide Network of Angel Investor Groups Announced in Alabama
10. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2011 Financial Results on Wednesday, March 7, 2012
11. Weikang Bio-Technology Group Co., Inc. Is Expected to Achieve the Net Profit of at Least $26 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... (PRWEB) , ... October 12, ... ... today announces publication of a United States multicenter, prospective clinical study that ... disposable, point-of-care diagnostic test capable of identifying clinically significant acute bacterial and ...
(Date:10/11/2017)... ... October 11, 2017 , ... At its national board meeting ... I. Sheikh, the co-founder, CEO and chief research scientist of Minnesota-based Advanced Space ... membership in ARCS Alumni Hall of Fame . ASTER Labs is a ...
(Date:10/11/2017)... ... 11, 2017 , ... Proscia Inc ., a data ... titled, “Pathology is going digital. Is your lab ready?” with Dr. Nicolas Cacciabeve, ... and how Proscia improves lab economics and realizes an increase in diagnostic confidence.* ...
(Date:10/11/2017)... ... October 11, 2017 , ... A ... pregnancy rates in frozen and fresh in vitro fertilization (IVF) transfer ... age to IVF success. , After comparing the results from the fresh and ...
Breaking Biology Technology:
(Date:4/5/2017)... 5, 2017  The Allen Institute for Cell Science ... a one-of-a-kind portal and dynamic digital window into the ... the first application of deep learning to create predictive ... lines and a growing suite of powerful tools. The ... and future publicly available resources created and shared by ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... the health IT company that operates the largest health ... today announced a Series B investment from BlueCross BlueShield ... investment and acquisition accelerates higi,s strategy to create the ... activities through the collection and workflow integration of ambient ... secures data today on behalf of over 36 million ...
Breaking Biology News(10 mins):